News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Sanofi-Aventis (France) to Buy Brazil’s Medley for About $700 Million
April 6, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PARIS, April 3 (Reuters) - France's Sanofi-Aventis (SASY.PA) plans to buy Brazilian generic drugmaker Medley next week for about $700 million, Le Figaro reported in a preview of its weekend edition without saying where it obtained the information.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Mergers & acquisitions
South America
Europe
Sanofi (France)
MORE ON THIS TOPIC
Deals
Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum
December 18, 2025
·
1 min read
·
BioSpace Insights
Layoffs
Voyager Throws 30 Staff Overboard After Novartis Sinks Two Programs
December 18, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
Roche Makes Good on Dealmaking Promise With $1.1B Caris Cancer Collab
December 17, 2025
·
1 min read
·
Tristan Manalac
Startups
Addition Debuts With $100M to Advance One-Time Therapies for Rare, Chronic Diseases
December 17, 2025
·
1 min read
·
Tristan Manalac
